Journal profile · Pharmacology & Pharmacy
Molecular Pharmaceutics
ISSN 1543-8384 · eISSN 1543-8392 · American Chemical Society · UNITED STATES · Monthly · Founded 2004
Molecular Pharmaceutics: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.95; transformative journal; APC about USD 4,500; median 124 days to acceptance (62 articles, last 24 months); community-reported acceptance: about 50%; 646 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Molecular Pharmaceutics is published by American Chemical Society and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are RNA Interference and Gene Delivery, Nanoparticle-Based Drug Delivery and Drug Solubulity and Delivery Systems, together about 30.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Molecular Pharmaceutics publishes findings on the molecular mechanistic understanding of drug delivery and drug delivery systems.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Lynne S. TaylorPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology11.4%
- Nanoparticle-Based Drug DeliveryMaterials Science9.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.9%
- Drug Transport and Resistance MechanismsMedicine6.3%
- Nanoplatforms for cancer theranosticsEngineering6%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.5%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology5.3%
- Crystallization and Solubility StudiesMaterials Science5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.95LetPub ·
- Impact factor (publisher)
- 4.9Publisher website ·
- CiteScore 2026-06
- 7.6LetPub ·
- CiteScore (publisher)
- 7.6Publisher website ·
- SJR 2026-06
- 0.96LetPub ·
- SNIP 2026-06
- 1.03LetPub ·
- h-index
- 110LetPub ·
- h-index
- 182OpenAlex ·
- i10-index
- 5,780OpenAlex ·
- 2-year mean citedness
- 5.1OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 20.04%LetPub ·
Volume
- Articles per year
- 572LetPub ·
Articles by year OpenAlex count · 8,256 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 389 | 105 | 237 |
| 2025 | 646 | 202 | 2,570 |
| 2024 | 551 | 184 | 5,285 |
| 2023 | 517 | 167 | 7,447 |
| 2022 | 467 | 138 | 8,513 |
| 2021 | 382 | 114 | 9,952 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
124 daysMedian, submission to acceptance · P25–P75 85 days – 149 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 62 articles with submission and acceptance dates (1,122 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Transformative journalLetPub
A subscription journal moving to full open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Chemical Society
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2004
- ISSN
- 1543-8384
- Electronic ISSN
- 1543-8392
- Latest issue on the website
- Volume 23, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Molecular Pharmaceutics
What CAS zone is Molecular Pharmaceutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Molecular Pharmaceutics is in Zone 2 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Molecular Pharmaceutics?
The latest impact factor listed by LetPub is 4.95; CiteScore 7.6, h-index 182.
How long does peer review take at Molecular Pharmaceutics?
Based on the dates recorded on 62 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 124 days (interquartile range 85–149 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Molecular Pharmaceutics?
According to LetPub and DOAJ records, Molecular Pharmaceutics is indexed in SCIE and Scopus.
Is Molecular Pharmaceutics open access, and what is the APC?
Molecular Pharmaceutics is a transformative journal. APC about USD 4,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .